Australian biotech CSL yesterday has delayed its planned vaccine division spin-off and cut earnings forecasts due to a bigger-than-expected decline in US flu vaccination rates, sending its shares down as much as 16.6%. Read full story
Date: 29 October, 2025 7:01 am
Source: thestar.com.my
💬 Join the Conversation! 💬
We’ve disabled comments on our posts and pages to keep the discussions organized and lively! But don’t worry – the conversation isn’t over. Head over to our forum and share your thoughts, ideas, and feedback with the community! It’s the perfect place to connect, learn, and engage with others who care about the same things. We can’t wait to hear from you!